Arcus Biosciences, Inc. (RCUS)

23.25 -0.45 (-1.90%) USD  |  NYSE  |  Apr 16, 15:11
More

Arcus Biosciences Operating Income (Annual)

Operating Income (Annual) Chart

View Operating Income (Annual) for RCUS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Operating Income (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Operating Income (Annual) Range, Past 5 Years

View Operating Income (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Operating Income (Annual) Benchmarks

View Operating Income (Annual) Benchmarks
Start Trial
Gilead Sciences, Inc. Upgrade
ACADIA Pharmaceuticals, Inc. Upgrade
Alnylam Pharmaceuticals, Inc. Upgrade
Regeneron Pharmaceuticals, Inc. Upgrade
Sarepta Therapeutics, Inc. Upgrade